The registry is currently funded by grants from the following industry partners:
Allergy Therapeutics
Bio-Diagnostics
Captium
Novartis
Thermo Fisher
Stallergenes Greer
If you would like to find out more about funding the BRIT Registry please complete the form below.
5 Mar 2026
Latest news,
26 Feb 2026